Novartis Financial Data
Novartis provides the following information on the Group's strong financial performance since its creation in 1996.
In this section
- Annual Results
- Novartis annual results conference, including media releases and year-to-date figures.
- Quarterly Results
- View recent and archived quarterly results.
- Novartis Annual Reporting Suite
- Read or download the Novartis Annual Review; download the Novartis Annual Report and Form 20-F, which contain our complete audited financial statements; and download the Novartis in Society ESG Report.
- SEC Filings
- Use the SEC’s EDGAR system to search and review all US disclosure filings by Novartis.
- Product Sales
- View sales data of major Novartis products by business franchise.
- Fixed-Income Securities
- Learn about the fixed-income securities issued by Novartis.
- Expected Currency Impact
- Expected currency impact, if currencies stay at mid-September levels for the rest of 2021.
Presentations and Events
View recent presentations and learn more about upcoming events
Contact Investor Relations
Investors International:
Call +41 61 324 79 44
Investors North America:
Call +1 862 778 5052
Novartis Share Registry:
For information relating to the registration of your shares, including name or address changes, please contact us by e‑mail or telephone:
Call +41 61 324 72 04